Pharmacological Reviews Get Tables of Contents delivered automatically
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     



0031-6997/05/5703-299-313$7.00
Pharmacol Rev 57:299-313, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodie, J. C.
Right arrow Articles by Humes, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodie, J. C.
Right arrow Articles by Humes, H. D.

Article

Stem Cell Approaches for the Treatment of Renal Failure

James C. Brodie and H. David Humes

Division of Nephrology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, Michigan

Abstract
I. Introduction
II. Direct Application of Stem Cells
    A. Transdifferentiation
    B. Bone Marrow-Derived Stem Cell Contribution to Kidneys
    C. Transdifferentiation Summary
    D. Renal Stem Cells
III. Tissue and Bioengineering Approaches
    A. Cellular Implants to Remove Toxins and Deliver Therapeutic Agents
    B. Renal Augmentation
    C. Full Renal Replacement
IV. Conclusions and Future Perspectives
Abstract

The inadequacy of current treatment modalities and insufficiency of donor organs for cadaveric transplantation have driven a search for improved methods of dealing with renal failure. The rising concept of cell-based therapeutics has provided a framework around which new approaches are being generated, and its combination with advances in stem cell research stands to bring both fields to clinical fruition. This budding partnership is presently in its very early stages, but an examination of the cell-based therapies currently under development clearly shows the magnitude of the role that stem cells will ultimately play. The issue over reports of unexpected plasticity in adult stem cell differentiation remains a focus of debate, and evidence for bone marrow-derived stem cell contributions to renal repair has been challenged. The search for adult renal stem cells, which could have a considerable impact on much of the work discussed here, appears to be narrowing. The use of embryonic tissue in research continues to provide valuable insights but will be the subject of intense societal scrutiny and debate before it reaches the stage of clinical application. Embryonic stem (ES) cells, with their ability to generate all, or nearly all, of the cell types in the adult body and a possible source of cells genetically identical to the donor, hold great promise but face ethical and political hurdles for human use. Immunoisolation of heterologous cells by encapsulation creates opportunities for their safe use as a component of implanted or ex vivo devices.


Address correspondence to: Dr. James C. Brodie, Department of Internal Medicine, University of Michigan School of Medicine, 4520 MSRB II 0651, 1150 W. Medical Center Dr., Ann Arbor, MI 48109. E-mail: jcbrodie{at}umich.edu







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition
Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics